Estimated risk and occurrence of breast cancer in asymptomatic and minimally symptomatic patients.
Mathematical procedures, some unique to this study, were applied to 114 suggested risk factors, with as many as 10 subsets, from history, physical and x-ray examination on 30,904 breast studies on 7,252 patients referred from the Emory University Clinic since 1963. One-fifth of the cancers were unrelated to symptoms; 82% of the cancers were free of axillary lymph node metastasis. There was no sign or symptom that predicted preclinical cancer. Interaction of numerous indicators subjected to strong statistical procedures could contribute to establishing risk of even early breast cancer. The results of hierarchic discriminant analyses demonstrated the feasibility of using simultaneously large numbers of risk factors in a systematic way to pinpoint patient with mammary cancer. Based on usual clinical and x-ray assessment of the women 12.5% of the noncancer patients required biopsy to demonstrate 70% of the cancers with a cancer to benign rate of 1 to 4. Using the same data with discriminant analyses, 5.6% of the patients would require biopsy, at the rate of 11.9% of the population. A computerized system has been developed for widespread application to provide the clinician with a highly objective and totally consistent assessment of risk for breast cancer in each of his patients.